BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

655 related articles for article (PubMed ID: 26159505)

  • 21. Polymyalgia rheumatica and giant cell arteritis-three challenges-consequences of the vasculitis process, osteoporosis, and malignancy: A prospective cohort study protocol.
    Emamifar A; Hess S; Gerke O; Hermann AP; Laustrup H; Hansen PS; Thye-Rønn P; Marcussen N; Svendstrup F; Gildberg-Mortensen R; Bang JC; Farahani ZA; Chrysidis S; Toftegaard P; Andreasen RA; le Greves S; Andersen HR; Olsen RN; Hansen IMJ
    Medicine (Baltimore); 2017 Jun; 96(26):e7297. PubMed ID: 28658131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Large vessel vasculitis and spondyloarthritis: coincidence or associated diseases?
    Ernst D; Baerlecken NT; Schmidt RE; Witte T
    Scand J Rheumatol; 2014; 43(3):246-8. PubMed ID: 24438209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic value of [18F]FDG-PET/CT for treatment monitoring in large vessel vasculitis: a systematic review and meta-analysis.
    van der Geest KSM; Treglia G; Glaudemans AWJM; Brouwer E; Sandovici M; Jamar F; Gheysens O; Slart RHJA
    Eur J Nucl Med Mol Imaging; 2021 Nov; 48(12):3886-3902. PubMed ID: 33942141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The value of ultrasound in diagnosing extracranial large-vessel vasculitis compared to FDG-PET/CT: A retrospective study.
    Löffler C; Hoffend J; Benck U; Krämer BK; Bergner R
    Clin Rheumatol; 2017 Sep; 36(9):2079-2086. PubMed ID: 28503707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decoding polymyalgia rheumatica, the role of Nuclear Medicine Imaging.
    Noriega-Álvarez E; Rodríguez-Alfonso B; Merino Argumánez C; Domínguez Gadea L; Peiró-Valgañón V
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2024; 43(1):63-72. PubMed ID: 38110086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA-B52 allele in giant cell arteritis may indicate diffuse large-vessel vasculitis formation: a retrospective study.
    Kushimoto K; Ayano M; Nishimura K; Nakano M; Kimoto Y; Mitoma H; Ono N; Arinobu Y; Akashi K; Horiuchi T; Niiro H
    Arthritis Res Ther; 2021 Sep; 23(1):238. PubMed ID: 34517892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The value of
    Schönau V; Vogel K; Englbrecht M; Wacker J; Schmidt D; Manger B; Kuwert T; Schett G
    Ann Rheum Dis; 2018 Jan; 77(1):70-77. PubMed ID: 28928271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positron Emission Computed Tomography Spectrum of Large Vessel Vasculitis in a Tertiary Center: Differences in 18F-fluorodeoxyglucose Uptake between Large Vessel Vasculitis with Predominant Cranial and Extracranial Giant Cell Arteritis Phenotypes.
    Heras-Recuero E; Landaeta-Kancev LC; Martínez de Bourio-Allona M; Torres-Rosello A; Blázquez-Sánchez T; Ferraz-Amaro I; Castañeda S; Martínez-López JA; Martínez-Dhier L; Largo R; González-Gay MÁ
    J Clin Med; 2023 Sep; 12(19):. PubMed ID: 37834808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contrast-Enhanced Ultrasound of the Carotid Artery in Patients With Large Vessel Vasculitis: Correlation With Positron Emission Tomography Findings.
    Germanò G; Macchioni P; Possemato N; Boiardi L; Nicolini A; Casali M; Versari A; Pipitone N; Salvarani C
    Arthritis Care Res (Hoboken); 2017 Jan; 69(1):143-149. PubMed ID: 27059104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Large vessel vasculitis in elderly patients: early diagnosis and steroid-response evaluation with FDG-PET/CT and contrast-enhanced CT.
    Muto G; Yamashita H; Takahashi Y; Miyata Y; Morooka M; Minamimoto R; Kubota K; Kaneko H; Kano T; Mimori A
    Rheumatol Int; 2014 Nov; 34(11):1545-54. PubMed ID: 24643395
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Rehak Z; Sprlakova-Pukova A; Kazda T; Fojtik Z; Vargova L; Nemec P
    Br J Radiol; 2017 Aug; 90(1076):20170198. PubMed ID: 28508663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PET/CT for Diagnosis and Management of Large-Vessel Vasculitis.
    Pelletier-Galarneau M; Ruddy TD
    Curr Cardiol Rep; 2019 Mar; 21(5):34. PubMed ID: 30887249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosing polymyalgia rheumatica on
    Yuge S; Nakatani K; Yoshino K; Koyama T
    Ann Nucl Med; 2018 Oct; 32(8):573-577. PubMed ID: 29948622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concomitant Polymyalgia Rheumatica and Large-Vessel Vasculitis Visualized on
    Maestri Brittain J; Gormsen LC; von Benzon E; Andersen KF
    Diagnostics (Basel); 2018 Apr; 8(2):. PubMed ID: 29690555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [
    Allard B; Devauchelle-Pensec V; Saraux A; Nowak E; Tison A; Boukhlal S; Guellec D; Jousse-Joulin S; Cornec D; Marhadour T; Le Pennec R; Salaün PY; Querellou S
    Eur J Nucl Med Mol Imaging; 2024 Apr; 51(5):1297-1309. PubMed ID: 38095675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of
    Pean de Ponfilly-Sotier M; Besson FL; Gomez L; Ottaviani S; Dieudé P; Pavy S; Mariette X; Seror R; Nocturne G
    Joint Bone Spine; 2022 May; 89(3):105325. PubMed ID: 34915108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in polymyalgia rheumatica: an observational study.
    Casadepax-Soulet C; Benali K; Crestani B; Piekarski E; Mahida B; Ebstein E; Juge PA; Forien M; Dieudé P; Ottaviani S
    Clin Exp Rheumatol; 2023 Jul; 41(7):1456-1462. PubMed ID: 36533978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Value of FDG-PET/CT for the Evaluation of Rheumatic Diseases: Rheumatoid Arthritis, Polymyalgia Rheumatica, and Relapsing Polychondritis.
    Kubota K; Yamashita H; Mimori A
    Semin Nucl Med; 2017 Jul; 47(4):408-424. PubMed ID: 28583280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imaging giant cell arteritis and Aortitis in contrast enhanced 18F-FDG PET/CT: Which imaging score correlates best with laboratory inflammation markers?
    Olthof SC; Krumm P; Henes J; Nikolaou K; la Fougère C; Pfannenberg C; Schwenzer N
    Eur J Radiol; 2018 Feb; 99():94-102. PubMed ID: 29362158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Value of (18)F-FDG PET/CT for therapeutic assessment of patients with polymyalgia rheumatica receiving tocilizumab as first-line treatment.
    Palard-Novello X; Querellou S; Gouillou M; Saraux A; Marhadour T; Garrigues F; Abgral R; Salaün PY; Devauchelle-Pensec V
    Eur J Nucl Med Mol Imaging; 2016 Apr; 43(4):773-9. PubMed ID: 26753600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.